In 1951 Leigh described a condition which is now known as subacute necrotizing encephalomyelopathy. Ebels, Blokzijl, and Troelstra (1965) have summarized findings in 28 of these patients, all of whom died. Since then 6 further cases have been described by Worsley et al. (1965) , Namiki (1965) , Lakke, Ebels, and ten Thye (1967) , and Clayton, Dobbs, and Patrick (1967) .
The metabolic background of this syndrome is not yet established. The biochemical abnormalities recorded have been (1) a persistently low plasma bicarbonate level, noted by Feigin and Wolf (1954) and confirmed in the 2 cases of Worsley et al. (1965) , and (2) high blood pyruvate and lactate levels observed in the 2 cases of Worsley et al. (1965) and in the cases described by Clayton et al. (1967) . Recently, Clayton et al. (1967) (see also Cromne and Stern, 1967) have reported treatment of this condition with lipoic acid, with some clinical benefit, as was also seen in the present case.
This paper describes a deficiency of the enzyme pyruvate carboxylase in the liver of a patient with this condition.
Methods
Glucose was determined by the method of HagedomJensen as used in the Technicon Autoanalyzer. Lactate and pyruvate were determined enzymatically according to Bergmeyer (1963) . Semiquantitative screening for aminoaciduria was conducted by high voltage electrophoresis on paper (Clotten and Clotten, 1962) . The liver biopsy, which was obtained with a Menghini needle, was homogenized in a Potter-Elvejhem homogenizer, with 10 mM tris hydroxymethylaminomethane buffer, pH 7 * 55, containing 2 mM EDTA.
The homogenate was used for the determination of phosphoenolpyruvate carboxykinase activity which was assayed as described by Nordlie and Lardy (1963) , and pyruvate carboxylase activity which was determined according to Utter and Keech (1963) . Received February 2, 1968. Case Report The patient is a brother of Case 3 described by Ebels et al. (1965) . He is the youngest of 7 children, 3 of whom died with the picture of progressive mental retardation, starting at an age varying from 3 to 6 months. hr.). CSF glucose was low (37 mg./100 ml., normal 50-70 mg./100 ml.), and protein raised (95 mg./100 ml.).
Glucose tolerance test was normal, except for a somewhat low fasting value (64 mg./100 ml.) (Fig. 1) . The response to intramuscular injection of glucagon and epinephrine was normal (Fig. 2 ). Blood lactate and pyruvate levels were 30 4 mg. and 4-4 mg./100 ml., 423 The blood lactate and pyruvate levels are also shown.
respectively, and these did not change during the glucose tolerance test (Fig. 1) (normal values 15 mg. and 0 5 mg./100 ml., respectively). These high values of blood lactate and pyruvate, combined with the low fasting blood glucose levels, suggested an impaired rate of gluconeogenesis, and it was decided to assay the liver enzymes responsible for the entrance of pyruvate into the gluconeogenetic pathway, pyruvate carboxylase, and phosphoenolpyruvate carboxykinase.
The activity of phosphoenolpyruvate carboxykinase was 3 * 4 ,tmoles ofoxaloacetate converted to phosphoenolpyruvate per minute per g. wet weight (Table) , which is well within the range of enzyme activities of gluconeogenesis as given by Krebs (1963 (Table) . This value is only 1/1000th of the value found in adult rat liver or in liver from human controls of the same age-group. (Specimens of human liver were obtained by open surgery from 2 patients with congenital anatomical disorders with hepatomegaly.) The normal value for phosphoenolpyruvate carboxykinase in the liver biopsy of our patient as compared with the controls (Table) makes it likely that a representative sample of liver has been biopsied.
Treatment. Lipoic acid was used, as suggested by Clayton et al. (1967) , at a dose rate of 0-7 mg./kg., intramuscularly 3 times a week. The effect of treatment on blood lactate and pyruvate levels is shown in Fig. 3 .
Two weeks after the start of treatment, the child's general condition was considerably improved. During the 5 weeks of treatment his weight increased from 5 9 (Ebels et al., 1965) , and the child described here must be assumed to be suffering from the same disorder. The finding of an almost total lack of pyruvate carboxylase activity in the liver makes it likely that this inborn error of metabolism is due to a lack of this enzyme. The fact that the activity of the enzyme phosphoenolpyruvate carboxykinase in liver was normal, confirmed that a representative sample of liver was obtained for enzyme assay. It also shows that the absence of pyruvate carboxylase activity was not accompanied by any general fall in activity of enzymes of gluconeogenesis.
Lactate, produced in peripheral tissue by glycolysis, is partly reconverted to glucose in the liver, and to a minor extent in some other tissues, such as kidney cortex. This process, known as gluconeogenesis, involves initially the chain of reactions shown in Fig. 4 . The absence of pyruvate carboxylase, as observed in this patient, could account for the persisting high pyruvate and lactate levels from blockage at the step where oxaloacetate is formed from pyruvate. It could also account for the low blood glucose level, because gluconeogenesis is greatly impaired, though, owing to the existence of alternative pathways (e.g. involving malate) for the production of oxaloacetate, it is not abolished. Worsley et al. (1965) have attributed the high values of blood lactate and pyruvate in this condition to a higher rate of glycolysis, rather than to an impaired rate of gluconeogenesis. A normal rate of glycolysis is evident from the normal glucose tolerance curve in both ours and Worsley's patients, and from the normal response to glucagon and epinephrine.
The beneficial effects of lipoic acid, as reported by Clayton et al. (1967) and Crome and Stern (1967) (Leigh, 1951; Ebels et al., 1965 metabolism of glutamic acid, notably transaminase reactions. Rolleston and Newsholme (1967) 
